Cranbrook Wealth Management, LLC Inmune Bio, Inc. Transaction History

Cranbrook Wealth Management, LLC

  • $468 Million
  • Q2 2025

A detailed history of Cranbrook Wealth Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Cranbrook Wealth Management, LLC holds 1,050 shares of INMB stock, worth $2,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,050
Previous 1,050 -0.0%
Holding current value
$2,541
Previous $7,000 71.43%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025
SELL
$4.93 - $10.48 $1,479 - $3,144
-300 Reduced 22.22%
1,050 $7,000
Q3 2024

Oct 15, 2024
BUY
$4.86 - $9.86 $6,561 - $13,311
1,350 New
1,350 $7,000

Others Institutions Holding INMB

# of Institutions
102
Shares Held
6.32M
Call Options Held
1.64M
Put Options Held
3.35M
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $43.4M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Cranbrook Wealth Management, LLC Portfolio

Follow Cranbrook Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cranbrook Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cranbrook Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email